| Literature DB >> 32801439 |
Nguyen Anh Tuan1, Nguyen Minh Duc2, Pham Van Hiep1, Than Van Sy3, Nguyen Van Du1, Ngo Tien Khuong1.
Abstract
INTRODUCTION: The e physical anatomical characteristics of Vietnamese people are similar to those of other East Asian populations, with a deep and narrow pelvis but an average body mass index (BMI) among patients at the advanced stage of rectal cancer. AIM: This study aimed to prospectively evaluate the short-term outcomes of transanal total mesorectal excision (TaTME) for rectal cancer treatment in a Vietnamese population.Entities:
Keywords: Consecutive Patients; Rectal Cancer; Transanal Total Mesorectal Excision; Vietnam
Mesh:
Year: 2020 PMID: 32801439 PMCID: PMC7405999 DOI: 10.5455/medarh.2020.74.216-223
Source DB: PubMed Journal: Med Arch ISSN: 0350-199X
Figure 1.(A) Purse-string was made. 1 cm from the tumor edge. (B) The initial resection.
Figure 2.The down-to-top dissection along the avascular plane.
Figure 3.The perineal phase stopped when the rectovaginal peritoneal reflection was identified.
Figure 4.Transanal withdrawl of the specimen (A). Handsewn (B) and stapled anastomosis (C)
Characteristics of patients. SD, standard deviation; ASA, American Society of Anesthesiologists; MRI, magnetic resonance imaging; T, tumor; N, node; M, Metastasis
| Characteristic | Data | |
|---|---|---|
| Age, years, mean ± SD (range) | 66.4 ± 11.7 (45–86) | |
| Sex, n (%) | Male | 43 (67.2) |
| Female | 21 (32.8) | |
| ASA score, n (%) | I | 8 (12.5) |
| II | 42 (65.7) | |
| III | 14 (21.9) | |
| Previous abdominal open surgery, n (%) | 9 (14) | |
| Tumor location, n (%) | Middle rectum | 38 (59.4) |
| Lower rectum | 26 (40.6) | |
| Distance from anal verge by MRI, cm, mean ± SD (range) | 4.7 ± 1.8 (1.5–8.2) | |
| Preoperative T stage, n (%) | cTx | 6 (9.4) |
| cT2 | 6 (9.4) | |
| cT3 | 47 (73.4) | |
| cT4a | 5 (7.8) | |
| Preoperative N stage, n (%) | cN+ | 48 (75) |
| cN - | 13 (20.3) | |
| Not assessed | 3 (4.7) | |
| Preoperative M stage, n (%) | M0 | 62 (96,8) |
| M1 | 2 (3.2) | |
| Neoadjuvant therapy, n (%) | Chemoradiation | 23 (35.9) |
| Chemotherapy | 1 (1.6) | |
| Radiation therapy | 26 (40.6) | |
Perioperative data in patients undergoing transanal total mesorectal excision
| Characteristic | Data (n = 64) | Clavien-Dindo classification | |
|---|---|---|---|
| Laparoscopic procedures, n (%) | 64 (100) | ||
| Internal sphincteric resection (ISR), n (%) | Total ISR | 18 (28.12) | |
| Subtotal ISR | 6 (9.37) | ||
| Ileostomy, n (%) | 35 (54.7) | ||
| Anastomosis, n (%) | Hand sewn | 51 (79.7) | |
| Stapled | 13 (20.3) | ||
| Operative time, min, mean ± SD (range) | 145.7 ± 22.6 | ||
| (100–225) | |||
| Estimated blood loss, ml, mean ± SD (range) | 73.4 ± 39.2 | ||
| (30–225) | |||
| Specimen extraction site, n (%) (Transanal) | 64 (100) | ||
| Intra-operative morbidity, n (%) | Bleeding | 1 (1.6) | |
| Rectal perforation | 1 (1.6) | ||
| Postoperative complications, n (%) | Urinary retention | 8 (12.5) | I |
| Bowel obstruction | 2 (3.2) | II | |
| Anastomotic leakage and stenosis | 1 (1.6) | IIIb | |
| Anastomotic leakage | 2 (3.2) | IIIa | |
| Rectovaginal fistula | 1 (1.6) | IIIb | |
| Anastomotic bleeding | 1 (1.6) | I | |
| Reoperation, n (%) | 3 (4.8) | ||
Histopathologic Characteristics of Surgical Specimens
| Characteristic | Data | |
|---|---|---|
| Quality of mesorectum, n (%) | Grade 3: complete | 53 (82.8) |
| Grade 2: nearly complete | 9 (14.1) | |
| Grade 1: incomplete | 2 (3.1) | |
| T staging | pT0 | 3 (4.8) |
| pT1 | 2 (3.2) | |
| pT2 | 17 (26.6) | |
| T3 | 37 (57.7) | |
| T4 | 5 (7.8) | |
| N staging | N0 | 43 (67.2) |
| N1 | 15 (23.4) | |
| N2 | 6 (9.4) | |
| Number of lymph nodes, mean ± SD | 12.4 ± 3.37 | |
| Tumor size, cm, mean ± SD | 5.17 ± 1.62 | |
| Distal margins, mm, mean ± SD | 2.37 ± 0.75 | |
| Positive | 0 | |
| Proximal margin, cm, mean ± SD | 13.27 ± 6.94 | |
| Positive | 0 | |
| CRM positive | 3 (4.8%) | |
Oncologic Outcomes
| Outcome | Data | |
|---|---|---|
| Follow-up, months, mean ± SD | 10.0 ± 3.9 | |
| Recurrence, n (%) | Disease-free survival | 63/64 (98.4) |
| Local and systemic recurrence | 1 (1.6) | |
| Port site recurrence | 0 (0) | |
| Survival, n (%) | Alive | 64 (100) |
| Dead | 0 (0) | |
Sphincter function outcomes
| Time, months | According to the Kirwan’s classification, n (%) | |||||
|---|---|---|---|---|---|---|
| I(very good) | II (good) | III (moderate) | IV (bad) | V (very bad) | Total | |
| 1 month | 0 | 0 | 6 (18.2) | 27 (81.8) | 0 | 33 (100) |
| 3 months | 0 | 5 (8.9) | 39 (69.7) | 12 (21.4) | 0 | 56 (100) |
| 6–9 months | 6 (11.1) | 17 (31.5) | 9 (16.7) | 21 (38.9) | 1 (1.6) | 54 (100) |
| 12 months | 16 (30.8) | 22 (42.3) | 14 (26.9) | 0 | 0 | 52 (100) |
BMI and pelvic anatomical characteristics BMI, body mass index.
| Male (n = 43) | Female (n = 21) | ||
|---|---|---|---|
| BMI (kg/m2) | 19.6 ± 2.4 | 20.9 ± 1.8 | 0.63 |
| (16.0–24.7) | (18.8–27) | ||
| Anteroposterior diameter of the pelvic inlet, mm | 10.81 ± 2.15 | 11.32 ± 1.36 | 0.04 |
| (9.56–11.75) | (10.15–12.74) | ||
| Transverse diameter of the pelvic inlet, mm | 11.69 ± 2.02 | 12.21 ± 2.33 | 0.03 |
| (11.12–12.56) | (11.28–12.48) | ||
| Anteroposterior diameter of the pelvic outlet, mm | 9.49 ± 1.67 | 10.23 ±1.32 | 0.05 |
| (8.71–10.31) | (9.01–10.93) | ||
| Transverse diameter of the pelvic outlet, mm | 10.12 ± 1.85 | 10.43 ± 1.45 | 0.06 |
| (9.67–10.68) | (9.87–11.08) | ||
| Pelvic depth, mm | 12.36 ± 2.03 | 11.73 ± 1.12 | 0.34 |
| (11.76–14.17) | (10.72–13.21) |